Breaking News

Rengan Rajaratnam Agrees to Settle Insider-Trading Case: SEC
Tweet TWEET

EDWARDS LIFESCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With

EDWARDS LIFESCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: 
Kahn Swick & Foti, LLC Reminds Investors With Losses in
Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit
Against Edwards Lifesciences Corp. - EW 
NEW ORLEANS, LA -- (Marketwired) -- 09/19/13 --  Kahn Swick & Foti,
LLC ("KSF") and KSF partner, the former Attorney General of
Louisiana, Charles C. Foti, Jr., remind investors that they have
until November 18, 2013 to file lead plaintiff applications in a
securities class action lawsuit against Edwards Lifesciences Corp.
(NYSE: EW), if they purchased the Company's securities during the
period between April 25, 2012 and April 23, 2013, inclusive (the
"Class Period"). This action is pending in the United States District
Court for the Central District of California. 
What You May Do 
If you purchased shares of Edwards Lifesciences and would like to
discuss your legal rights and how this case might affect you and your
right to recover for your economic loss, you may, without obligation
or cost to you, call toll-free at 1-877-515-1850, or email KSF
Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com) or KSF
Partner Melinda Nicholson (melinda.nicholson@ksfcounsel.com). If you
wish to serve as a lead plaintiff in this class action, you must
petition the Court by November 18, 2013.  
About the Lawsuit 
Edwards Lifesciences and certain of its executives are charged with
issuing a series of materially false and misleading statements during
the Class Period, violating federal securities laws.  
These false statements and omissions included, in part, that: (i)
adoption of the Company's Edwards SAPIEN transcatheter aortic heart
valve, including the related transfemoral and transapical delivery
methods, was weaker than the Company claimed, due to concerns among
physicians over the risks and complexity of the procedure for
implanting the valve; (ii) Edwards Lifesciences' outlook for sales
and earnings per share was significantly weaker than the optimistic
guidance defendants offered to investors; and (iii) as a result,
defendants lacked a reasonable basis for the statements made
concerning the Company's operations, forecasts and outlook. 
About Kahn Swick & Foti, LLC 
To learn more about KSF, whose partners include the Former Louisiana
Attorney General, Charles C. Foti, Jr., and other lawyers with
significant experience litigating complex securities class actions
nationwide on behalf of both institutional and individual
shareholders, you may visit www.ksfcounsel.com. 
Contact: 
Kahn Swick & Foti, LLC
Lewis Kahn
Managing Partner
lewis.kahn@ksfcounsel.com
Melinda Nicholson
Partner
melinda.nicholson@ksfcounsel.com
1-877-515-1850
206 Covington St.
Madisonville, LA 70447 
 
 
Press spacebar to pause and continue. Press esc to stop.